IMNN - Imunon Inc
IEX Last Trade
1.14
0.050 4.386%
Share volume: 319,409
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.09
0.05
4.59%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-11 | 2023-08-10 | 2023-11-14 | |
| Assets | ||||||||
| Total Assets | 64.341 M | 65.328 M | 60.531 M | 43.976 M | 42.106 M | 28.722 M | 24.654 M | |
| Current Assets | 43.866 M | 44.911 M | 40.194 M | 37.155 M | 36.332 M | 26.732 M | 21.725 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.545 M | 2.768 M | 2.811 M | 2.778 M | 2.790 M | 2.640 M | 2.251 M | |
| Short Term Investments | 2.545 M | 2.768 M | 2.811 M | 2.778 M | 2.790 M | 2.640 M | 2.251 M | |
| Total Receivables | 15.646 K | 29.728 K | 30.495 K | 128.932 K | 116.355 K | 80.489 K | 97.103 K | |
| Current Cash | 41.306 M | 42.114 M | 37.352 M | 32.747 M | 31.176 M | 24.011 M | 19.377 M | |
| Total Non-current Assets | 20.475 M | 20.417 M | 20.337 M | 6.821 M | 5.774 M | 1.990 M | 2.929 M | |
| Property Plant Equipment | 487.530 K | 561.662 K | 582.531 K | 548.301 K | 555.929 K | 651.231 K | 823.551 K | |
| Other Assets | 58.761 K | 58.761 K | 93.761 K | 50.000 K | 50.000 K | 50.000 K | 441.440 K | |
| Intangible Assets | 13.366 M | 13.366 M | 13.366 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 64.341 M | 65.328 M | 60.531 M | 43.976 M | 42.106 M | 28.722 M | 24.654 M | |
| Total liabilities | 18.076 M | 18.285 M | 19.180 M | 14.648 M | 15.459 M | 7.207 M | 6.583 M | |
| Total current liabilities | 6.649 M | 6.891 M | 8.465 M | 10.037 M | 10.418 M | 6.124 M | 5.317 M | |
| Accounts Payable | 3.474 M | 2.393 M | 3.370 M | 3.587 M | 3.973 M | 2.612 M | 1.827 M | |
| Other liabilities | 5.396 M | 5.396 M | 5.396 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 670.513 K | 1.425 M | 2.181 M | 0.000 | 0.000 | |
| Long term debt | 5.900 M | 5.945 M | 5.320 M | 4.611 M | 3.899 M | 0.000 | 0.000 | |
| Other liabilities | 5.396 M | 5.396 M | 5.396 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 46.265 M | 47.042 M | 41.351 M | 29.328 M | 26.647 M | 21.515 M | 18.072 M | |
| Common stock | 5.770 M | 6.982 M | 7.099 M | 8.721 M | 8.281 M | 9.137 M | 9.377 M | |
| Retained earnings | -343.244 M | -349.287 M | -355.435 M | -368.668 M | -374.259 M | -379.818 M | -383.295 M |